Clinical Laserthermia Systems: Comment on the report

Research Note

2020-02-28

08:46

The Q4 report did not include any major surprises and the main interest among investors in the coming months will likely be on news regarding the Thermoguide Software, additional orders from the US as well as further information about the upcoming proof-of-concept study in imILT.

EN

Erik Nordström

Sign up for free to continue

Already a member?

Sign in

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.